Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2024: 5.34%

Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) is 5.34% for the year ending December 31, 2024, a -0.38% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023 was 5.36%, a -21.56% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 6.84%, a -4.50% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 7.16%, a -2.12% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 7.32%, a 15.99% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share